154 related articles for article (PubMed ID: 22224083)
1. Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies.
Sayan M; Akhan SC; Senturk O
Hepat Mon; 2011 Oct; 11(10):835-42. PubMed ID: 22224083
[TBL] [Abstract][Full Text] [Related]
2. Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.
Wang Y; Liu S; Chen YU; Zheng S; Zhou LI; Lu F; Duan Z
Exp Ther Med; 2016 Jun; 11(6):2293-2299. PubMed ID: 27313669
[TBL] [Abstract][Full Text] [Related]
3. Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.
Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
J Gastroenterol Hepatol; 2010 Aug; 25(8):1374-80. PubMed ID: 20659226
[TBL] [Abstract][Full Text] [Related]
4. Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants.
Chen CH; Wang JH; Lu SN; Hu TH; Hung CH; Chang MH; Changchien CS; Lee CM
Antivir Ther; 2012; 17(4):701-9. PubMed ID: 22358132
[TBL] [Abstract][Full Text] [Related]
5. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.
Liu Y; Wang C; Zhong Y; Li X; Dai J; Ren X; Xu Z; Li L; Yao Z; Ji D; Wang L; Zhang L; Wong VW; Zoulim F; Xu D
J Viral Hepat; 2011 Apr; 18(4):e29-39. PubMed ID: 21392168
[TBL] [Abstract][Full Text] [Related]
6. Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B.
Arrese E; Basaras M; Blanco S; Ruiz P; Cisterna R
Ann Hepatol; 2011; 10(4):434-40. PubMed ID: 21911882
[TBL] [Abstract][Full Text] [Related]
7. Delayed Reduction of Hepatitis B Viral Load and Dynamics of Adefovir-Resistant Variants during Adefovir plus Entecavir Combination Rescue Therapy.
Wang Y; Liu S; Chen Y; Zheng S; Zhou L; Lu F; Duan Z
Int J Med Sci; 2015; 12(5):416-22. PubMed ID: 26005376
[TBL] [Abstract][Full Text] [Related]
8. Rescue therapy for lamivudine-resistant chronic hepatitis B: adefovir monotherapy, adefovir plus lamivudine or entecavir combination therapy.
Ha M; Zhang G; Diao S; Lin M; Wu J; Sun L; She H; Shen L; Huang C; Shen W; Huang Z
Intern Med; 2012; 51(12):1509-15. PubMed ID: 22728482
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy.
Kim SS; Cho SW; Kim SO; Hong SP; Cheong JY
J Med Virol; 2013 Jan; 85(1):55-64. PubMed ID: 23096938
[TBL] [Abstract][Full Text] [Related]
10. [Determination of reverse transcriptase inhibitor nucleoside analogue resistance profile in pretreatment phase of patients with viral hepatitis B].
Öksüz Z; Serin MS; Serin A; Sezgin O; Gonca S
Mikrobiyol Bul; 2019 Apr; 53(2):156-169. PubMed ID: 31130120
[TBL] [Abstract][Full Text] [Related]
11. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
Mirandola S; Sebastiani G; Rossi C; Velo E; Erne EM; Vario A; Tempesta D; Romualdi C; Campagnolo D; Alberti A
Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant hepatitis B virus strain in a chronic Turkish patient.
Sayan M; Hulagu S; Karatayli SC
Hepat Mon; 2010; 10(2):141-6. PubMed ID: 22312387
[TBL] [Abstract][Full Text] [Related]
13. Add-on adefovir is superior to a switch to entecavir as rescue therapy for Lamivudine-resistant chronic hepatitis B.
Chung GE; Kim W; Lee KL; Hwang SY; Lee JH; Kim HY; Jung YJ; Kim D; Jeong JB; Kim BG; Kim YJ; Yoon JH; Lee HS
Dig Dis Sci; 2011 Jul; 56(7):2130-6. PubMed ID: 21253834
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China.
Qian F; Qin J; Li D; Ma Z; Zhang H; Jin F; Wang W
J Infect Dev Ctries; 2016 Sep; 10(9):996-1002. PubMed ID: 27694733
[TBL] [Abstract][Full Text] [Related]
15. Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure.
Zoulim F; Białkowska-Warzecha J; Diculescu MM; Goldis AE; Heyne R; Mach T; Marcellin P; Petersen J; Simon K; Bendahmane S; Klauck I; Wasiak W; Janssen HL
Hepatol Int; 2016 Sep; 10(5):779-88. PubMed ID: 27206517
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
Ji FZ; Wang L; Yang BH; Zhao JJ; Liu F; Xue Y; Li T
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):280-4. PubMed ID: 22964149
[TBL] [Abstract][Full Text] [Related]
17. Comparison of lamivudine plus adefovir therapy versus entecavir with or without adefovir therapy for adefovir-resistant chronic hepatitis B.
Kang SH; Yim HJ; Kim HR; Kang K; Suh SJ; Lee HJ; Yoon EL; Kim JH; Seo YS; Yeon JE; Byun KS
J Clin Gastroenterol; 2014; 48(10):889-95. PubMed ID: 24440937
[TBL] [Abstract][Full Text] [Related]
18. Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir.
Choe WH; Hong SP; Kim BK; Ko SY; Jung YK; Kim JH; Yeon JE; Byun KS; Kim KH; Ji SI; Kim SO; Lee CH; Kwon SY
Antivir Ther; 2009; 14(7):985-93. PubMed ID: 19918102
[TBL] [Abstract][Full Text] [Related]
19. Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy.
Chon YE; Jin B; Ahn SH; Kim S; Kim ND; Park JH; Nam CM; Kim KH; Hong SP; Choi SH; Kim DY; Park JY; Han KH
Liver Int; 2015 Nov; 35(11):2370-83. PubMed ID: 25872678
[TBL] [Abstract][Full Text] [Related]
20. Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.
Heo NY; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Hepatol; 2010 Sep; 53(3):449-54. PubMed ID: 20646776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
